Stay updated on Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial page.

Latest updates to the Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe page’s footer release/revision label has been updated from v3.5.2 to v3.5.3, indicating a site/version maintenance update rather than a change to the clinical trial study details.SummaryDifference0.0%

- Check8 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedAdded a new Resources entry: Cutaneous neuroendocrine carcinoma with Genetic and Rare Diseases Information Center.SummaryDifference0.1%

- Check37 days agoChange Detected- Revision labels updated: added v3.5.0 and removed v3.4.3.SummaryDifference0.0%

- Check44 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check73 days agoChange DetectedThe page shows a minor update: Revision v3.4.2 was added and Revision v3.4.1 was removed. This update affects only metadata and does not alter study content or user-facing functionality; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial page.